Selected Leadership Engagements
Experience in Medical Affairs, Real-World Evidence, and Strategic Operations
These selected leadership engagements highlight how Sibindi Life Sciences leads complex Medical Affairs, Real-World Evidence (RWE), and strategic operations initiatives—from multicenter vaccine safety studies to portfolio governance and public health programs.
National Vaccine RWE Study Leadership
- US$2M+ budget management
- Multicenter observational Phase IV vaccine safety study
- 1,200+ participants enrolled
- 15-member cross-functional leadership
Strategic Development Portfolio Governance
- US$7M strategic development portfolio
- Executive-level reporting and decision support
- Risk management and issue escalation
- Vendor oversight and contract governance
Rare Disease Medical Affairs Consulting
- Asia-Pacific regional Medical Affairs support
- Scientific communications and publication planning
- KOL engagement and advisory activities
KOL Engagements & Scientific Partnerships
- Cultivated partnerships with 45+ Key Opinion Leaders nationally
- Shaped strategy through medical insights generation
- Supported launch readiness and product lifecycle management
- Aligned cross-functional stakeholders to drive priorities
Improved Governance
Implemented global governance frameworks for a US$7M strategic development portfolio and complex post-marketing studies, strengthening oversight, accountability, and decision-making.
Accelerated Delivery
Optimized multicenter observational study execution, enabling efficient enrollment, risk mitigation, and evidence-generation timelines for high-stakes vaccine safety programs.
Strengthened Networks
Expanded and managed Asia-Pacific and global KOL networks, enhancing scientific exchange, stakeholder alignment, and long-term strategic partnerships.
